Navigation Links
SRI International Completes Biosciences Facility Expansion in Shenandoah Valley, Virginia
Date:10/24/2013

" Wang, Ph.D., Senior Scientist, Virology, Center for Immunology and Infectious Diseases: Wang studies the entry mechanism of Hepatitis C virus (HCV) and natural immunity against viruses. His current research includes characterizing the role of the occludin protein in HCV entry and how HCV infection alters the physiology of tight junctions, the areas between cells where membranes join together. Prior to joining SRI, Wang was a faculty member in the University of Pittsburgh's Department of Infectious Diseases and Microbiology.
  • Lynn Chellarajan, Laboratory Supervisor: Chellarajan is the operational manager of SRI's new SRI SV preclinical laboratories and oversees the daily operation of a broad range of toxicology and pharmacology studies conducted to advance promising therapeutics from the discovery stage towards human clinical trials. Prior to joining SRI, she spent more than a decade working in the pharmaceutical industry at PharmaMar USA, Millennium, and Eisai. Chellarajan is actively recruiting additional staff to support SRI's expanding preclinical activities.
  • "In 2007, a small number of SRI colleagues and I first began working in a laboratory on the campus of James Madison University, which marked the founding of our Center for Advanced Drug Research in Shenandoah Valley. Since then, due in large part to the support of the Commonwealth of Virginia and other regional partners, we have grown and established a state-of-the-art facility tackling the challenges of drug discovery and development for critical and emerging diseases," said Krishna Kodukula, Ph.D., executive director, strategic development and site head of SRI Shenandoah Valley. "Tom Voss, Tony Wang, and Lynn Chellarajan, the most recent staff members to join our team from around the world, are valuable assets in SRI's expanded research cap
    '/>"/>

    SOURCE SRI International
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Biocartis Presents the Successful use of Idylla[TM] for the Detection of the BRAF Mutation Status in Tumour Samples at the International AACR Congress (American Association for Cancer Research) in Boston
    2. 3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    3. Dyadic International Extends All Debt Maturity Dates
    4. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
    5. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
    6. CIVCO Names Darrell Newcombe as Vice President of International Sales for Radiation Oncology
    7. Paul Kauffman of Accident Fund to Present on Identifying Risky Opioid Prescribing Patterns at 99th Annual International Association of Industrial Accident Boards & Commissions Conference
    8. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
    9. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
    10. WIKA Process Solutions, Deer Park, Texas Acquires Gayesco International.
    11. PAREXEL International To Present At Robert Baird Healthcare Conference And Raymond James North American Equities Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/30/2015)... 30, 2015  Astellas Pharma Inc. (TSE: 4503) today ... on the safety, tolerability and efficacy of ASP2215, a ... refractory (R/R) acute myeloid leukemia (AML) were presented during ... Clinical Oncology,s (ASCO) annual meeting in Chicago ... kinase inhibitor of FLT3 and AXL, which are involved ...
    (Date:5/30/2015)... Wash. and VANCOUVER, British Columbia ... Inc. (NASDAQ: OGXI ) announced today that results ... trial showed a benefit with custirsen therapy in men ... poor prognosis. The analysis, exploring the effect of clusterin ... that over 40 percent of men in the trial ...
    (Date:5/30/2015)... y SPARTANBURG , Carolina ... - Nueva colaboración para ampliar drásticamente ... con cáncer en los Estados Unidos   ... Health proporcionarán a los pacientes con cáncer apoyo ... Guardian Research Network y Molecular Health han anunciado ...
    Breaking Medicine Technology:Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 2Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4
    ... Masimo (NASDAQ: MASI ) announced today that ... (RRa™) was presented at the New York ... Meeting in New York City. The new ... outcomes and patient safety impact of Masimo,s unique Acoustic Respiration ...
    ... /PRNewswire-iReach/ -- Physicians, Capital Investments, LLC (PCI/the ... and medical investment solutions is pleased to announce ... to Dallas, TX. The new headquarters, centrally located ... Company,s real estate development, business development and administrative ...
    Cached Medicine Technology:New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 2New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 4New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 5Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 2Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 3
    (Date:5/30/2015)... 2015 Blueair, a world leader in ... work and leisure, revealed the new IoT face of ... Design event in Los Angeles, California, running May 29 ... the editors of Dwell magazine, gives visitors three full ... 2,000 innovative modern products, including the world’s most intelligent ...
    (Date:5/30/2015)... On Sunday, June 14, 2015, The Rosenfeld Cancer ... host Journey to Survivorship, a celebration for cancer survivors ... for cancer survivors and their families will be provided. ... Kathy LaTour, editor-at-large for Cure magazine. Initially diagnosed with ... LaTour provides a unique perspective to her inspiring message, ...
    (Date:5/30/2015)... Danbury, CT (PRWEB) May 30, 2015 ... Americans do not always get better health outcomes than ... is expensive and not always safe" states author Dr. ... In Health Attitude: Unraveling and Solving the Complexities ... in terms even newcomers to the healthcare policy debate ...
    (Date:5/30/2015)... Twelve of the nation’s leading oncology physicians, ... the 2015 Giants of Cancer Care at ... Company last night. The awardees included medical pioneers selected ... in translational research, gene therapy, immuno-oncology and other groundbreaking ... , Honorees were introduced and celebrated during the third ...
    (Date:5/30/2015)... Israel and Montreal, Canada (PRWEB) May 30, 2015 ... print process control, and quality assurance, is joining forces ... advanced offline inspection solutions to the worldwide printing market. ... provide AVT with a new software engine for its ... specific needs of the printing industry and its varying ...
    Breaking Medicine News(10 mins):Health News:Blueair unveils clean air intelligence at Dwell on Design Show LA for optimal indoor air 2Health News:Abington Hospital to Host Cancer Survivorship Event 2Health News:"Health Attitude", a new book by Dr. John R. Patrick, explains the American healthcare system, what is wrong with it, and how to fix it. 2Health News:"Health Attitude", a new book by Dr. John R. Patrick, explains the American healthcare system, what is wrong with it, and how to fix it. 3Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 2Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 3Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 4Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3
    ... CHICAGO --- Teresa Woodruff, the Thomas J. Watkins Professor ... of Medicine, received the prestigious Presidential Award for Excellence ... House from President Barack Obama Monday, Dec. 12. ... called the Women,s Health Science Program for High School ...
    ... , FRIDAY, Dec. 16 (HealthDay News) -- Men often ... a new study finds. In what should come as no ... a certain type of guy tends to think all women want ... the cues. The study included 96 male and 103 female ...
    ... Europe provide plentiful food in summer, finding enough to eat ... avoid the problem by hibernating but this survival strategy is ... of some bears, large mammals remain fully awake throughout the ... with the comparative scarcity of food. Red deer, for ...
    ... for cystic fibrosis produced sustained improvement in lung function ... study. Along with the treatment,s efficacy and good safety ... treatment may improve adherence with therapy in these patients. ... Pharmaxis Limited, 318 patients were randomized to treatment with ...
    ... with HIV, immediate antiretroviral therapy (ART) appears preferable to ... the Journal of Infectious Diseases and now ... HIV-1 infection remain unproven, the findings support growing evidence ... the Medical College of Wisconsin in Milwaukee, led a ...
    ... Dec. 15 (HealthDay News) -- Reusing pacemakers from dead ... study. It involved 53 heart patients in Mumbai, ... deceased American patients. The pacemakers were sterilized before they ... the pacemakers, all the patients were alive and doing ...
    Cached Medicine News:Health News:Northwestern scientist gets mentoring award at White House 2Health News:Northwestern scientist gets mentoring award at White House 3Health News:Men Often Misread Women's Sexual Cues: Study 2Health News:Winter diets? The secret is to chill the extremities 2Health News:Winter diets? The secret is to chill the extremities 3Health News:Long-term inhaled dry powder mannitol improves lung function in CF 2Health News:Study suggests early ART in recently HIV-infected patients preferable to delayed treatment 2Health News:Donated Pacemakers From U.S. Safely Reused in India: Study 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: